Drugs@FDA: FDA-Approved Drugs
New Drug Application (NDA): 215319
Company: LAURUS GENERICS INC
Company: LAURUS GENERICS INC
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
DOLUTEGRAVIR | DOLUTEGRAVIR | 5MG | FILM;ORAL | Prescription | None | No | No |
DOLUTEGRAVIR | DOLUTEGRAVIR | 10MG | FILM;ORAL | Prescription | None | No | No |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
04/28/2023 | ORIG-1 | Tentative Approval | Type 5 - New Formulation or New Manufacturer | PRIORITY |
Letter (PDF)
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/215319Orig1s000TAltr.pdf |